tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CYBN Stock Latest News

Psychedelic: Exclusive talk with biotech company Enveric Biosciences
The FlyPsychedelic: Exclusive talk with biotech company Enveric Biosciences
2d ago
ATAI
CMND
Cybin price target lowered to $150 from $190 at H.C. Wainwright
PremiumThe Fly
Cybin price target lowered to $150 from $190 at H.C. Wainwright
9d ago
CYBN
Cybin price target lowered to $73 from $86 at Canaccord
PremiumThe Fly
Cybin price target lowered to $73 from $86 at Canaccord
10d ago
CYBN
Cybin Accelerates PARADIGM Program for Depression Treatment
PremiumCompany Announcements
Cybin Accelerates PARADIGM Program for Depression Treatment
12d ago
CYBN
Psychedelic: Relmada acquires neurosteroid from Asarina
PremiumThe Fly
Psychedelic: Relmada acquires neurosteroid from Asarina
16d ago
ATAI
CMND
Psychedelic: atai Life Sciences reports BPL-003 study results
PremiumThe FlyPsychedelic: atai Life Sciences reports BPL-003 study results
23d ago
ATAI
CMND
Cybin’s depression program advancing in Phase 3, says H.C. Wainwright
Premium
The Fly
Cybin’s depression program advancing in Phase 3, says H.C. Wainwright
26d ago
CYBN
Cybin Partners with Segal Trials for Pivotal Phase 3 Program
Premium
Company Announcements
Cybin Partners with Segal Trials for Pivotal Phase 3 Program
1M ago
CYBN
Cybin launches clinical site partnerships to support PARADIGM program
PremiumThe Fly
Cybin launches clinical site partnerships to support PARADIGM program
1M ago
CYBN
Cybin Inc. Achieves Breakthroughs in Mental Health Treatment
PremiumCompany Announcements
Cybin Inc. Achieves Breakthroughs in Mental Health Treatment
1M ago
CYBN
Cybin files $650M mixed securities shelf
PremiumThe Fly
Cybin files $650M mixed securities shelf
2M ago
CYBN
Cybin Reveals Promising Results in Depression Treatment
PremiumCompany Announcements
Cybin Reveals Promising Results in Depression Treatment
2M ago
CYBN
Cybin to Discuss Breakthrough Treatments at Fireside Chat
PremiumCompany AnnouncementsCybin to Discuss Breakthrough Treatments at Fireside Chat
3M ago
CYBN
Cybin Inc. Advances in Mental Health Treatments
Premium
Company Announcements
Cybin Inc. Advances in Mental Health Treatments
3M ago
CYBN
Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
Premium
The Fly
Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
3M ago
ACB
CGC
Cybin’s CYB003 Shows Promising Results for Depression
PremiumCompany Announcements
Cybin’s CYB003 Shows Promising Results for Depression
3M ago
CYBN
Cybin: CYB003 data demonstres ‘breakthrough 12-month efficacy’ in MDD treatment
PremiumThe Fly
Cybin: CYB003 data demonstres ‘breakthrough 12-month efficacy’ in MDD treatment
3M ago
CYBN
Rising High: Cannabis firms report quarterly earnings
PremiumThe Fly
Rising High: Cannabis firms report quarterly earnings
3M ago
ACB
CGC
Cybin to Showcase Promising Depression Treatment Progress
PremiumCompany Announcements
Cybin to Showcase Promising Depression Treatment Progress
3M ago
CYBN
Cybin to Present Promising CYB003 Study Results
PremiumCompany AnnouncementsCybin to Present Promising CYB003 Study Results
3M ago
CYBN
Cybin price target lowered to $86 from $96 at Canaccord
Premium
The Fly
Cybin price target lowered to $86 from $96 at Canaccord
3M ago
CYBN
Cybin target adjusted to $25 at Alliance Global Partners following stock split
Premium
The Fly
Cybin target adjusted to $25 at Alliance Global Partners following stock split
3M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >